January 16, 2025 -- Today, Public Health Director Dr. Grant Colfax announced his resignation from the San Francisco Department of Public Health (SFDPH) after nearly six years.

I want to highlight three key areas in which USAID engaged with our African partners this year to address both opportunities ...

Your trendy health cure may not only be useless, it could also land you in the ER. As a growing number of people eschew ...

We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are going to take a look at where ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

A new report has shed light on the struggles of HIV-positive Palestinians living in Gaza, where medication is running out.

The U.S. initiative to fight HIV globally, PEPFAR, is at a crossroad where it must focus on sustainable health systems and ...

Gilead Sciences Inc. and the federal government settled a patent-infringement case in which the US sought $1 billion from the ...

Terms of the deal were not disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and ...

The flagship U.S. aid program on HIV/AIDS is in jeopardy, a senior Republican warned on Thursday, after U.S. officials said four nurses in Mozambique performed abortions that are banned under the ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

The director of NIAID is appointed by the head of the NIH, who must be approved by the Senate. Directors have broad ...